Plasma Adiponectin, Clinical Factors, and Patient Outcomes during the Acute Respiratory Distress Syndrome

@inproceedings{Walkey2014PlasmaAC,
  title={Plasma Adiponectin, Clinical Factors, and Patient Outcomes during the Acute Respiratory Distress Syndrome},
  author={Allan J Walkey and Serkalem Demissie and Dilip Shah and Freddy Romero and Leah Puklin and Ross S. Summer and J{\"o}rn Karhausen},
  booktitle={PloS one},
  year={2014}
}
OBJECTIVE Adiponectin (APN) is an anti-inflammatory hormone derived from adipose tissue that attenuates acute lung injury in rodents. In this study, we investigated the association between circulating APN and outcomes among patients with acute respiratory distress syndrome (ARDS). METHODS We performed a retrospective cohort study using data and plasma samples from participants in the multicenter ARDS Network Fluid and Catheter Treatment Trial. RESULTS Plasma APN concentrations were measured… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 25 references

National Institutes of Health/National Heart, Lung, and Blood Institute ARDS Network

  • TM Bull, B Clark, K McFann, M Moss
  • Am J Respir Crit Care Med
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…